Insmed (INSM) Other Non-Current Liabilities (2011 - 2026)

Insmed (INSM) recorded quarterly Other Non-Current Liabilities of $5.7 million in Q1 2026, down 98.19% quarter-over-quarter from $314.3 million in Q4 2025, and down 96.96% on a YoY basis from $187.2 million in Q1 2025.

Insmed (INSM) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Insmed's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 96.96% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (down 96.96% YoY), while the FY2025 annual figure was $314.3 million, up 86.11% from the prior year.
  • Other Non-Current Liabilities was $5.7 million for Q1 2026 at Insmed, down from $314.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $314.3 million in Q4 2025 to a low of $5.6 million in Q2 2025.
  • Historically, Other Non-Current Liabilities has averaged $76.7 million across 5 years, with a median of $60.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Other Non-Current Liabilities surged 1043.24% in 2023, then sank 96.96% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $7.4 million in 2022, then soared by 1043.24% to $84.6 million in 2023, then soared by 99.65% to $168.9 million in 2024, then jumped by 86.11% to $314.3 million in 2025, then plunged by 98.19% to $5.7 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $5.7 million (Q1 2026), $314.3 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.68 Mn
Dec 31, 2025 314.34 Mn
Sep 30, 2025 5.60 Mn
Jun 30, 2025 5.56 Mn
Mar 31, 2025 187.20 Mn
Dec 31, 2024 168.90 Mn
Jun 30, 2024 12.40 Mn
Mar 31, 2024 73.40 Mn
Dec 31, 2023 84.60 Mn
Sep 30, 2023 69.90 Mn
Jun 30, 2023 61.70 Mn
Mar 31, 2023 49.80 Mn
Dec 31, 2022 7.40 Mn
Sep 30, 2022 59.30 Mn
Jun 30, 2022 55.60 Mn
Mar 31, 2022 66.12 Mn
Dec 31, 2021 75.67 Mn
Sep 30, 2021 23.88 Mn
Jun 30, 2021 12.81 Mn
Mar 31, 2021 9.30 Mn